EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal Hydrogen–Methane Breath Testing for Suspected Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Patient-Level Associations and Repeat-Test Outcomes

Rana Taha, Dana Ledawi, Meital Izhakov, Yair Huta, Olga Ashorov, Tsachi Tsadok Perets

Journal of Clinical Medicine · 18.11.2026 · 15 (22) · 9056

DOI: 10.3390/jcm15229056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.11.2026. Verfasst von Rana Taha und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Hydrogen–methane breath testing is widely used for suspected small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO), but longitudinal test behavior is poorly characterized. We quantified laboratory normalization at first repeat testing and examined whether index-test hydrogen magnitude was associated with subsequent laboratory status.

Methods

This retrospective cohort included breath tests with simultaneous hydrogen and methane measurement performed during 2022–2025. The earliest valid test was the index test. Hydrogen (H2) positivity was defined as a >20-ppm rise above baseline and methane (CH4) positivity according to the historical institutional laboratory operational definition as a >10-ppm rise above baseline; this definition is distinct from conventional IMO classification based on absolute CH4 ≥ 10 ppm. Multivariable logistic regression assessed associations with index positivity and positive-to-negative conversion. All patients with a positive index test who underwent repeat testing reported completing first-line rifaximin before retesting.

Results

Among 3082 patients (3446 valid tests), index-test positivity was 48.2%. Increasing age was associated with lower overall positivity (adjusted odd ratio (OR) per 10 years 0.904, 95% confidence interval (CI) 0.871–0.938; p < 0.001), driven by H2 rather than CH4. Of 1487 patients with a positive index test, 279 (18.8%) underwent repeat testing, and 96/279 (34.4%) showed laboratory normalization. Among 262 patients with H2-positive index tests, each 10-ppm increase in index-test hydrogen rise (ΔH2) was associated with lower odds of normalization (adjusted OR 0.844, 95% CI 0.757–0.940; p = 0.002).

Conclusions

Among selected patients with a positive index test undergoing post-treatment repeat testing, approximately one-third showed laboratory normalization. Greater index-test ΔH2 was associated with lower odds of normalization within the group of patients with H2-positive index tests. These findings do not establish a validated clinical prediction tool.

Zitieren

APA

Taha, R., Ledawi, D., Izhakov, M., Huta, Y., Ashorov, O., & Perets, T. T. (2026). Longitudinal Hydrogen–Methane Breath Testing for Suspected Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Patient-Level Associations and Repeat-Test Outcomes. Journal of Clinical Medicine, 15(22), 9056. https://doi.org/10.3390/jcm15229056

Vancouver

Taha R, Ledawi D, Izhakov M, Huta Y, Ashorov O, Perets TT. Longitudinal Hydrogen–Methane Breath Testing for Suspected Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Patient-Level Associations and Repeat-Test Outcomes. Journal of Clinical Medicine. 2026;15(22):9056. doi:10.3390/jcm15229056

BibTeX
@article{Taha2026,
  author = {Taha, Rana and Ledawi, Dana and Izhakov, Meital and Huta, Yair and Ashorov, Olga and Perets, Tsachi Tsadok},
  title = {Longitudinal Hydrogen–Methane Breath Testing for Suspected Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Patient-Level Associations and Repeat-Test Outcomes},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {9056},
  doi = {10.3390/jcm15229056}
}
Kostenlos starten →